One hundred sixty-nine patients underwent replacement of the aortic valve with an aortic valve homograft; of these patients 17 had concomitant commissurotomy or annuloplasty for an associated mitral valve lesion. Homografts were prepared by sterilization with beta-propiolactone solution and stored in Hanks' solution, or 
T HE OCCURRENCE of thromboembolic complications following the insertion of aortic ball valve prostheses, and, therefore, the demonstrated need for longterm anticoagulant therapy to The valve was excised with a portion of the ascending aorta, the upper portion of the left ventricle, and part of the anterior leaflet of the mitral valve. Excess muscular and fibroareolar tissues were trimmed from the external surface of the graft. The graft was rinsed in water to remove all blood, and the diameter of the valve was measured with a calibrated obturator. The graft was then sealed in a plastic bag, and that bag sealed in two others. Glass beads were placed in the outer bag, and an appropriate identifying tag was inserted. Because the glass beads turn black when irradiated, they serve to indicate that the graft has been treated; they do not, however, reflect quantitatively the dose of radiation energy.
The bags were stored in a carbon dioxide freezer at -70 C. Later they were sterilized while still frozen with a 6 Mev electron beam extracted from the linear accelerator which is routinely used for supervoltage X-ray therapy in our institution; this provided an absorbed dose of ionizing radiation of approximately 2.5 megarads in the 25 min of exposure. The effectiveness of the sterilization procedure has been verified by irradiating numerous samples which had been deliberately heavily contaminated with a variety of microorganisms.
After irradiation, the valves were catalogued and stored at -70 C until they were used. It is not known how long homografts might be stored, but valves have been discarded arbitrarily after a 12-month period.
Operative Technique A median sternotomy incision is used, and the right atrial appendage and ascending aorta are cannulated for extracorporeal circulation. The left ventricle is vented by a vent inserted through a stab wound. The aorta is cross-clamped, and an oblique aortotomy incision is made extending down into the sinus of the noncoronary cusp. The trimmed of all excess tissue in such a manner as to provide a straight-line sewing margin beneath the valve leaflets. The aorta is trimmed above the leaflets to leave a 1-mm scalloped margin of aorta which conforms to the attachment of the valve leaflets. Early in our experience we used the technique of B3ai.ratt-1Boyes2-for inserting the valve. This technique has been modified, and currently a valve holder is used ( fig. 1 ). The valve is inverted, tumined inside out, and placed on the valve holder. Interrupted sutures for the inferior suture line are then placed through the valve and through the recipient root on a horizontal plane beneath the margins of excision of the excised valve. The valve is removed from the valve holder and lowered into the left ventricle. The sutures are tied and the valve is inverted again to return it to its normal position.
The superior suture line is placed by using three double-arm sutures in a continuous technique ( fig. 2 ). Each suture is started at the base of a coronary sinus, and each end is continued up the commissures and tied to the adjacent suture at the apex of the commissures.
It is of great importance that the commissures be adequately suspended and properly spaced ( fig. 3 ). It is important that the commissures be spaced in relation to the homograft rather than to the line of excision of the diseased valve. This is particularly true when the root has required tailoring, since tailoring alters the distance between the commissures of the host root. The 
Results

Early Results
Mortality
There were nine hospital deaths in this series of 169 patients, for an operative mortality of 5.3% ( placed on anticoagulant therapy postoperatively. Four patients (2.5%) who survived operation had definite or probable embolic complications. One patient with a severely calcified valve had a cerebral embolus 2 days postoperatively resulting in hemiparesis. Another patient with atrial fibrillation developed hemiparesis 1 month postoperatively. Two other patients had transient neurologic deficits thought to be secondary to embolism; both of these patients had had concomitant mitral valve surgery.
Bacterial Endocarditis
Bacterial endocarditis was responsible for two late deaths, at 38 and 40 months postoperatively. In both instances, streptococci of the viridans group was cultured. A third patient developed aortic valve incompetence 18 months postoperatively, and a clinical diagnosis of subacute bacterial endocarditis was made; however, this was not proved bacteriologically. This patient died 52 months postoperatively from congestive heart failure, having refused reoperation. In one patient, in whom an infected ball valve prosthesis was replaced with a homograft that subsequently required replacement because of a perforated cusp, the perforation was suspected to be secondary to infection of the valve.
Calcification of Homografts
Calcification of the homograft valve was looked for roentgenographically at the time of follow-up and was noted in only one patient 31 months postoperatively; it was minimal, and the patient was asymptomatic without evidence of valve dysfuncton. Calcification of valve leaflets was not present in any of the patients who required reoperation or in any of the valves examined post mortem.
Symptoms
There were 156 patients who had been operated on at least 6 months to 54 months prior to the time of this report (table 4). One hundred thirty-two (84%) were alive and asymptomatic or markedly improved over their preoperative status; six of these patients have required reoperation. Fifty-eight (43%) of the patients had an aortic diastolic murmur. However, there were only five patients who had significant valve incompetence, and four of these patients were asymptomatic or improved. One patient was unimproved. Two patients had no cardiac symptoms but were considered to be disabled because of neurologic deficits secondary to embolic episodes.
Twenty-three patients were operated on at least 4 years ago. Nineteen (83%) of these patients are alive and well 48 to 54 months postoperatively. Eleven of them had an aortic diastolic murmur, but none of these patients has significant homograft valve incompetence.
Discussion
Although the ball valve prosthesis is an effective replacement for the aortic valve, certain disadvantages are associated with its use. Some of these disadvantages are overcome by the use of an aortic valve homograft.
Experience has shown that an aortic valve homograft can be inserted with a low operative mortality, one similar to that of any other type of aortic valve replacement. The operative mortality in this series of patients with isolated aortic valve disease was 5%, with only one death in the last 69 cases.
The operative technique has become standardized. The bypass time required for the insertion of an aortic valve homograft is 60 to 75 min. This is approximately 15 to 20 min longer than that required for the insertion of a prosthetic valve. For this reason we have not used a homograft in a few cases where advanced coronary artery disease precluded the use of coronary artery perfusion.
An enlarged aortic root can be tailored to conform to the size of available grafts, as was done in 57 (34%) of the patients in this series. However, in certain cases of aortic valve incompetence-those, for instance, associated with aortic dissection, or those with markedly dilated roots in which the incompetence is secondary to disease of the aortic root as in Marfan's syndrome-a homograft is not used. In such situations, a ball valve prosthesis is used because the rigid sewing ring prevents recurrent dilatation of the aortic root. Aortic valve homografts are not used when a prosthetic valve is used to replace the mitral or tricuspid valve; a primary advantage of the homograft is lost in that these patients require anticoagulant therapy postoperatively.
There may be advantages to using a fresh homograft in preference to a preserved graft. These advantages would, however, appear to be offset by the problem of procurement of fresh valves and the difficulty in maintaining a valve bank with a variety of sizes.
Although the data from this series are insufficient to permit comparison of those homografts sterilized in beta-propiolactone and stored in Hanks' solution with those sterilized by irradiation and preserved by freezing, experimental work suggests that the latter technique is preferable.6 In the three patients who required reoperation because of a central valve incompetence without disruption of the cusps, the valves used had been sterilized in beta-propiolactone; it is possible that shrinkage of leaflet tissue, reported to occur with this preparation, may have been a factor in allowing this incompetence to occur. Valves preserved by freezing have a better consistency and are easier to work with than are valves preserved in solution.
Five of the six patients who required reoperation had evidence of significant valve incompetence within 6 months of the initial operation. This suggests that the technique of insertion, improper sizing of the valve, and insufficiency of leaflet tissue surface might be more important factors in valve dysfunction than degeneration of the leaflet tissue.
The incidence of early diastolic murmurs had decreased to less than 10% in the last 50 patients in the series, as compared with an overall incidence of 19%. This decrease in incidence of early diastolic murmurs may be a result of improved technique with increased experience, although here, too, it may be significant that valves preserved by freezing were used in the last half of the series whereas valves preserved in solution were used in the first half. It was unusual for a patient to develop significant valve incompetence if there was no diastolic murmur at the time of hospital dismissal. Only two of 111 patients without a diastolic murmur at the time of hospital dismissal and followed for at least 6 months developed significant valve incompetence requiring reoperation.
A major advantage of a homograft valve is that anticoagulant therapy is not required postoperatively, and the incidence of thromboembolic complications is minimal. Four patients in this series had probable or definite embolic episodes. In one patient, who had a cerebral embolus immediately postoperatively, the embolus was thought to be a calcific fragment. The three other patients had had concomitant mitral valve surgery or had atrial fibrillation.
It was initially thought that bacterial endocarditis would be an insignificant problem with homograft valves; this, however, has not been our experience. Two deaths were a direct result of bacterial infection of the valve, and one other patient died as a result of fungal infection of the valve. Two other patients were suspected of having subacute bacterial endocarditis although this was not proved bacteriologically. It is recommended that prophylactic antibiotic therapy be used during periods of increased susceptibility to bacteremia.
There was one unexplained death in the 12 patients who died after hospital dismissal. Of the five patients who had incompetence of the homograft that was thought to be a contributing cause of death, three could have been reoperated on; however, they refused reoperation. The other two patients had bacterial endocarditis of the valves, and probably should have been operated on earlier in the course of their illness.
Eighty-four per cent of the patients who have been followed for 6 to 54 months are asymptomatic or markedly improved over their preoperative status, although six have required reoperation. It is of interest that, of the 23 patients followed for more than 48 months, 19 are alive and well (one has required reoperation). In none of these patients is there evidence of significant valve incompetence. Of the four deaths, two were operative deaths and two were late deaths. One of these late deaths was caused by bacterial endocarditis and the other by a myocardial infarction.
This experience supports the continued use of aortic valve homografts in most patients requiring replacement of the aortic valve. Long-term results are comparable to those of prosthetic valve replacement, and homograft use has a distinct advantage in that anticoagulant therapy is not required postoperatively.
